Open Access<p>Levonorgestrel Ameliorates Adenomyosis via lncRNA H19/miR-17/TLR4 Pathway</p>
Author(s) -
Na Liang,
Wenfeng Zhang,
Hongjiang Wang,
Shi We,
Li Wang,
Lijuan Ma
Publication year - 2020
Publication title -
drug design, development and therapy
Language(s) - Uncategorized
Resource type - Journals
ISSN - 1177-8881
DOI - 10.2147/dddt.s248095
Subject(s) - tlr4 , adenomyosis , cancer research , stromal cell , western blot , endometrium , microrna , messenger rna , chemistry , andrology , microbiology and biotechnology , biology , signal transduction , medicine , endometriosis , endocrinology , gene , biochemistry
To explore the mechanism of levonorgestrel (LNG)-ameliorating adenomyosis through long non-coding RNA H19 (lncRNA H19)/miR-17/Toll-like receptor 4 (TLR4) pathway.